Myomo, Inc. (NYSEAMERICAN:MYO – Get Free Report) Director Milton Mayo Morris bought 15,000 shares of the firm’s stock in a transaction dated Friday, September 8th. The shares were acquired at an average cost of $1.06 per share, with a total value of $15,900.00. Following the completion of the transaction, the director now owns 77,933 shares of the company’s stock, valued at $82,608.98. The purchase was disclosed in a legal filing with the SEC, which is available at this link.
Myomo Price Performance
Shares of NYSEAMERICAN:MYO traded up $0.06 during midday trading on Monday, hitting $1.12. 1,650,459 shares of the company’s stock were exchanged, compared to its average volume of 602,475. The company has a market cap of $23.63 million, a PE ratio of -1.44 and a beta of 0.90. Myomo, Inc. has a 12 month low of $0.37 and a 12 month high of $1.81.
Myomo (NYSEAMERICAN:MYO – Get Free Report) last issued its quarterly earnings data on Wednesday, August 9th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.04). Myomo had a negative net margin of 49.70% and a negative return on equity of 106.09%. The business had revenue of $5.96 million during the quarter, compared to the consensus estimate of $5.75 million. On average, equities research analysts expect that Myomo, Inc. will post -0.33 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Myomo
Wall Street Analyst Weigh In
Separately, Maxim Group started coverage on shares of Myomo in a research report on Thursday, May 25th. They set a “buy” rating for the company.
Myomo Company Profile
Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
- Five stocks we like better than Myomo
- Investing in Construction Stocks
- An Electrifying New Upgrade for Tesla Leads the Market Higher
- Bank Stocks – Best Bank Stocks to Invest In
- Oil Jumps, 2 Plastic Stocks About To Become Value Plays
- What is a Non-Fungible Token (NFT)? Definition and How it Works
- The Top 5 Analysts Calls in September
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.